Category: News & Events

Small Molecules to Treat Cardiovascular Disease: Cardiac Myosin Inhibitors

Cardiac myosin inhibitorsAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. A new study demonstrates that a multimodal large language model (LLM) can accurately support preoperative planning for transcatheter aortic valve replacement (TAVR). By integrating CT imaging and clinical data, the system automatically generates structured surgical plans, including valve selection, access strategy, and risk alerts. Tested across 950 patients, the model showed high agreement with expert heart teams while reducing planning time by over 90%. The findings highlight the potential of LLM-driven tools to improve efficiency and decision-making in complex cardiac procedures. (more…)

Loading

LLM-Based Multimodal Planning for TAVR: Independent Validation, Calibration, and Efficiency Gains

TAVR, multimodal LLMAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. A new study demonstrates that a multimodal large language model (LLM) can accurately support preoperative planning for transcatheter aortic valve replacement (TAVR). By integrating CT imaging and clinical data, the system automatically generates structured surgical plans, including valve selection, access strategy, and risk alerts. Tested across 950 patients, the model showed high agreement with expert heart teams while reducing planning time by over 90%. The findings highlight the potential of LLM-driven tools to improve efficiency and decision-making in complex cardiac procedures. (more…)

Loading

Experience in Providing Emergency Care for Myocardial Infarction in Armenia

Myocardial InfarctionAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. The article highlights Armenia’s significant progress in strengthening its cardiology care system, including nationwide access to primary percutaneous coronary intervention (pPCI) and a state-funded program that has treated approximately 23,000 patients since 2015 while reducing in-hospital STEMI mortality to as low as 2–3%. The editorial provides a comprehensive overview of the country’s diagnostic capacity, infrastructure, and evolving national initiatives, including the expansion of free revascularization to all myocardial infarction patients and the introduction of a national registry (ARMI) to support data-driven improvements. While noting ongoing challenges such as regional disparities in access, pre-hospital delays, and the need for enhanced rehabilitation and prevention strategies, the authors emphasize (more…)

Loading

Timing of Complete Revascularization in STEMI: Insights From the OPTION–STEMI Trial

RevascularizationAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. This editorial examines the findings of the OPTION–STEMI trial and their implications for the management of patients with ST-segment elevation myocardial infarction (STEMI) and multivessel coronary artery disease.

While current guidelines recommend complete revascularization, the trial investigated whether non-culprit lesions should be treated immediately or in a staged procedure during the same hospital admission. The study found that immediate complete revascularization did not demonstrate non-inferiority compared with staged treatment.

Notably, patients with acute heart failure showed worse outcomes with immediate intervention, suggesting that a staged approach during the index hospitalization may be safer for higher-risk patients. (more…)

Loading

When Surgery Fails: The Role of Transcatheter Closure in Treating Giant Coronary Cameral Fistulas

Giant coronary cameral fistulaeAnnouncing a new article publication for Cardiovascular Innovations and Applications journal. This article describes the successful transcatheter closure of a giant coronary cameral fistula in an infant after two unsuccessful surgical attempts.

The patient, a 4-month-old infant with severe heart failure symptoms, was diagnosed with a large fistula connecting the left anterior descending coronary artery to the right ventricle. After surgical ligation failed due to recanalization and high-flow physiology, clinicians adopted a transcatheter rescue strategy. (more…)

Loading

Transcatheter Tricuspid Valve Intervention Plus Optimized Medical Therapy Versus Optimized Medical Therapy Alone in Tricuspid Regurgitation: A Systematic Review and Meta-Analysis

Announcing a new article publication for Cardiovascular Innovations and Applications journal.  Tricuspid regurgitation (TR) is common and associated with substantial morbidity and mortality. Although optimized medical therapy (OMT) can alleviate symptoms, it may be insufficient in severe cases, and surgical interventions carry considerable procedural risk, limiting their use; consequently, tricuspid transcatheter valve interventions (TTVIs) have emerged as a less invasive alternative. The authors of this article conducted a systematic search of PubMed, Scopus, and Web of Science to identify randomized clinical trials and observational studies comparing TTVI plus OMT versus OMT alone. The primary outcome was all-cause mortality, and secondary outcomes included heart failure (HF) hospitalization and a combined outcome of all-cause mortality and HF hospitalization.

(more…)

Loading

Expanded Use of Transcatheter Aortic Valve Replacement in Patients with Low Surgical Risk

Announcing a new article publication for Cardiovascular Innovations and Applications journal. This commentary reviews the role of transcatheter aortic valve replacement (TAVR) in patients with severe aortic stenosis who are at low surgical risk. Recent clinical trials show that TAVR provides outcomes comparable to surgical aortic valve replacement (SAVR) over mid-term follow-up, while offering potential benefits such as faster recovery. The authors emphasize that treatment decisions should consider patient age, anatomy, comorbidities, and long-term planning for future valve interventions.

(more…)

Loading

Emerging Novel Biomarkers in Acute Coronary Syndrome Management: Insights and Future Directions

Announcing a new article publication for Cardiovascular Innovations and Applications journal.   Acute coronary syndrome (ACS), a primary manifestation of coronary artery disease (CAD), remains a leading cause of global mortality, particularly in low- and middle-income countries. Despite advances in diagnostics and therapy, accurate early risk stratification of ACS remains challenging. Traditional biomarkers such as cardiac troponins and CK-MB are essential for diagnosis but do not capture the full complexity of disease severity, particularly in cases involving inflammation, endothelial dysfunction and plaque instability. This review highlights emerging evidence regarding the roles of inflammatory cytokines and novel biomarkers in ACS pathophysiology, diagnosis and prognostication.

(more…)

Loading

Burden of Hypertensive Disorders of Pregnancy: A Trend Study from 1990 to 2021 with Risk Factor and Dietary Analysis

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Hypertensive disorders of pregnancy (HDP), the third leading cause of maternal mortality worldwide, account for approximately 16% of all maternal deaths. The incidence and mortality rates of HDP vary across regions.

This study was aimed at examining global trends in HDP prevalence from 1990 to 2021, identifying major risk factors associated with HDP-related mortality, and assessing the influence of dietary habits on HDP risk.

(more…)

Loading

Amino Acid Regulation in Metabolic Heart Disease: Mechanisms and Therapeutic Potential

Announcing a new article publication for Cardiovascular Innovations and Applications journal.  In normal cardiac energy metabolism, 95% of the heart’s energy is provided by mitochondria, and preferences for energy-providing substrates vary at different. However, prolonged metabolic alterations impair cardiac function. Therefore, this study primarily focuses on the relationship between amino acid metabolism and diabetic cardiomyopathy and atherosclerosis.

(more…)

Loading